Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Nov 2023 for Acura Pharmaceuticals, INC.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Peter A. Clemens: trading record in brief
Peter A. Clemens is a declared insider of Acura Pharmaceuticals, Inc, with filings sourced from SEC (Form 4). Between 3 August 2022 and 20 November 2023, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 20 November 2023 came the latest disclosure, an option exercise in Acura Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter A. Clemens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
40,000 sharesCommon StockSEC:0001104659-23-119812:0
40,000 sharesCommon StockSEC:0001104659-23-001411:0
49,333 sharesCommon StockSEC:0001104659-22-086709:0
3 of 3 declarations
